You are here

P&T December 2019


Strict policies are needed to protect patients.

New treatmetnt has rapid onset of action.

Identifying the best evidence for DOAC use in certain populations.

Case Report
A Case Report of Thrombocytosis in a Patient Receiving Ciprofloxacin and Ceftriaxone

Case report points to risk of ciprofloxacin–ceftriaxone combination.


Men might have benefited from getting a more complete ED story.


A good bye from Pharmacy and Therapeutics.


Prescription Washington

Congress divided on drug pricing legislation.

Istradefylline (Nourianz) as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease experiencing “off” episodes.